These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

431 related articles for article (PubMed ID: 29337962)

  • 1. The relationship between right-sided tumour location, tumour microenvironment, systemic inflammation, adjuvant therapy and survival in patients undergoing surgery for colon and rectal cancer.
    Patel M; McSorley ST; Park JH; Roxburgh CSD; Edwards J; Horgan PG; McMillan DC
    Br J Cancer; 2018 Mar; 118(5):705-712. PubMed ID: 29337962
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Tumour invasiveness, the local and systemic environment and the basis of staging systems in colorectal cancer.
    Park JH; van Wyk H; Roxburgh CSD; Horgan PG; Edwards J; McMillan DC
    Br J Cancer; 2017 May; 116(11):1444-1450. PubMed ID: 28427085
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The relationship between tumour site, clinicopathological characteristics and cancer-specific survival in patients undergoing surgery for colorectal cancer.
    Powell AG; Wallace R; McKee RF; Anderson JH; Going JJ; Edwards J; Horgan PG
    Colorectal Dis; 2012 Dec; 14(12):1493-9. PubMed ID: 22507826
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The prognostic value of systemic inflammation in patients undergoing surgery for colon cancer: comparison of composite ratios and cumulative scores.
    Dolan RD; McSorley ST; Park JH; Watt DG; Roxburgh CS; Horgan PG; McMillan DC
    Br J Cancer; 2018 Jul; 119(1):40-51. PubMed ID: 29789606
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The prognostic impact of primary tumour location in patients with stage II and stage III colon cancer receiving adjuvant therapy. A GISCAD analysis from three large randomised trials.
    Cascinu S; Poli D; Zaniboni A; Lonardi S; Labianca R; Sobrero A; Rosati G; Di Bartolomeo M; Scartozzi M; Zagonel V; Pella N; Banzi M; Torri V
    Eur J Cancer; 2019 Apr; 111():1-7. PubMed ID: 30797014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Determinants of lymph node count and positivity in patients undergoing surgery for colon cancer.
    Dolan RD; McSorley ST; Horgan PG; McMillan DC
    Medicine (Baltimore); 2018 Mar; 97(13):e0185. PubMed ID: 29595652
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prognostic impact of primary tumor location in Stage III colorectal cancer-right-sided colon versus left-sided colon versus rectum: a nationwide multicenter retrospective study.
    Shida D; Inoue M; Tanabe T; Moritani K; Tsukamoto S; Yamauchi S; Sugihara K; Kanemitsu Y
    J Gastroenterol; 2020 Oct; 55(10):958-968. PubMed ID: 32651860
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mismatch repair status in patients with primary operable colorectal cancer: associations with the local and systemic tumour environment.
    Park JH; Powell AG; Roxburgh CS; Horgan PG; McMillan DC; Edwards J
    Br J Cancer; 2016 Mar; 114(5):562-70. PubMed ID: 26859693
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Adjuvant chemotherapy for stage II right-sided and left-sided colon cancer: analysis of SEER-medicare data.
    Weiss JM; Schumacher J; Allen GO; Neuman H; Lange EO; Loconte NK; Greenberg CC; Smith MA
    Ann Surg Oncol; 2014 Jun; 21(6):1781-91. PubMed ID: 24643898
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prognostic impact of primary tumour location after curative resection in Stage I-III colorectal cancer: a single-centre retrospective study.
    Inoue M; Kanemitsu Y; Tsukamoto S; Moritani K; Takamizawa Y; Daiko H
    Jpn J Clin Oncol; 2024 Jul; 54(7):753-760. PubMed ID: 38535894
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of right- and left-sided colonic and rectal cancer following surgical resection.
    Suttie SA; Shaikh I; Mullen R; Amin AI; Daniel T; Yalamarthi S
    Colorectal Dis; 2011 Aug; 13(8):884-9. PubMed ID: 20594201
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The prognostic value of combined measures of the systemic inflammatory response in patients with colon cancer: an analysis of 1700 patients.
    Golder AM; McMillan DC; Park JH; Mansouri D; Horgan PG; Roxburgh CS
    Br J Cancer; 2021 May; 124(11):1828-1835. PubMed ID: 33762720
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The relationship between the local and systemic inflammatory responses and survival in patients undergoing curative surgery for colon and rectal cancers.
    Roxburgh CS; Salmond JM; Horgan PG; Oien KA; McMillan DC
    J Gastrointest Surg; 2009 Nov; 13(11):2011-8; discussion 2018-9. PubMed ID: 19768511
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Impact of age on the use of adjuvant treatments in patients undergoing surgery for colorectal cancer: patients with stage III colon or stage II/III rectal cancer.
    Sarasqueta C; Perales A; Escobar A; Baré M; Redondo M; Fernández de Larrea N; Briones E; Piera JM; Zunzunegui MV; Quintana JM;
    BMC Cancer; 2019 Jul; 19(1):735. PubMed ID: 31345187
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The differential impact of microsatellite instability as a marker of prognosis and tumour response between colon cancer and rectal cancer.
    Hong SP; Min BS; Kim TI; Cheon JH; Kim NK; Kim H; Kim WH
    Eur J Cancer; 2012 May; 48(8):1235-43. PubMed ID: 22071131
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant chemotherapy for resected colon cancer: comparison of the prognostic value of tumour and patient related factors.
    Roxburgh C; McDonald A; Salmond J; Oien K; Anderson J; McKee R; Horgan P; McMillan D
    Int J Colorectal Dis; 2011 Apr; 26(4):483-92. PubMed ID: 21212966
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Prognostic value of tumour necrosis and host inflammatory responses in colorectal cancer.
    Richards CH; Roxburgh CS; Anderson JH; McKee RF; Foulis AK; Horgan PG; McMillan DC
    Br J Surg; 2012 Feb; 99(2):287-94. PubMed ID: 22086662
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Peripheral Neutrophil to Lymphocyte Ratio Improves Prognostication in Colon Cancer.
    Rashtak S; Ruan X; Druliner BR; Liu H; Therneau T; Mouchli M; Boardman LA
    Clin Colorectal Cancer; 2017 Jun; 16(2):115-123.e3. PubMed ID: 28365393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Effect of preoperative neutrophil-lymphocyte ratio on the surgical outcomes of stage II colon cancer patients who do not receive adjuvant chemotherapy.
    Hung HY; Chen JS; Yeh CY; Changchien CR; Tang R; Hsieh PS; Tasi WS; You JF; You YT; Fan CW; Wang JY; Chiang JM
    Int J Colorectal Dis; 2011 Aug; 26(8):1059-65. PubMed ID: 21479566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Prognostic value of inflammation-based scores in patients receiving radical resection for colorectal cancer.
    Wang F; He W; Jiang C; Guo G; Ke B; Dai Q; Long J; Xia L
    BMC Cancer; 2018 Nov; 18(1):1102. PubMed ID: 30419863
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.